Healthcare provider profile · identity verified

Thomas I Lecher, M.D.

Internal Medicine · HOWARD BEACH, NY · NPI 1053408781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	463	133
Atorvastatin Calcium	Atorvastatin Calcium	462	133
Rosuvastatin Calcium	Rosuvastatin Calcium	342	104
Metoprolol Succinate	Metoprolol Succinate	319	93
Levothyroxine Sodium	Levothyroxine Sodium	296	87
Losartan Potassium	Losartan Potassium	289	83
Simvastatin	Simvastatin	287	80
Omeprazole	Omeprazole	214	66
Metformin Hcl	Metformin Hcl	175	51
Hydrochlorothiazide	Hydrochlorothiazide	143	43
Furosemide	Furosemide	137	50
Tamsulosin Hcl	Tamsulosin Hcl	126	41
Glimepiride	Glimepiride	119	34
Lisinopril	Lisinopril	104	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	28
Metformin Hcl Er	Metformin Hcl	98	32
Atenolol	Atenolol	92	28
Synthroid	Levothyroxine Sodium	89	25
Zolpidem Tartrate	Zolpidem Tartrate	89	17
Pantoprazole Sodium	Pantoprazole Sodium	84	23
Allopurinol	Allopurinol	79	26
Albuterol Sulfate Hfa	Albuterol Sulfate	78	26
Metoprolol Tartrate	Metoprolol Tartrate	76	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	73	17
Ramipril	Ramipril	73	19
Meloxicam	Meloxicam	66	35
Nifedipine Er	Nifedipine	65	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	63	51
Gabapentin	Gabapentin	60	26
Azithromycin	Azithromycin	59	51
Escitalopram Oxalate	Escitalopram Oxalate	57	16
Famotidine	Famotidine	56	16
Fluticasone Propionate	Fluticasone Propionate	55	26
Methylprednisolone	Methylprednisolone	53	49
Azelastine Hcl	Azelastine Hcl	51	35
Carvedilol	Carvedilol	51	16
Potassium Chloride	Potassium Chloride	50	13
Clopidogrel	Clopidogrel Bisulfate	49	17
Donepezil Hcl	Donepezil Hcl	49	16
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Montelukast Sodium	Montelukast Sodium	48	12
Sertraline Hcl	Sertraline Hcl	46	12
Ezetimibe	Ezetimibe	44	14
Ozempic	Semaglutide	44	12
Eliquis	Apixaban	43	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	18
Olmesartan Medoxomil	Olmesartan Medoxomil	41	11
Pravastatin Sodium	Pravastatin Sodium	41	12
Enalapril Maleate	Enalapril Maleate	40	13
Valsartan	Valsartan	40	16
Alprazolam	Alprazolam	39	suppressed
Jardiance	Empagliflozin	39	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Glipizide Er	Glipizide	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	32	11
Irbesartan	Irbesartan	32	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Prednisone	Prednisone	30	26
Buspirone Hcl	Buspirone Hcl	28	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	23
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Finasteride	Finasteride	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	15
Benazepril Hcl	Benazepril Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	18
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Glipizide	Glipizide	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Trazodone Hcl	Trazodone Hcl	17	suppressed
Rybelsus	Semaglutide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Vascepa	Icosapent Ethyl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Metolazone	Metolazone	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Diazepam	Diazepam	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error